Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Human Pheromone Sciences, Inc. was a biotechnology company focused on the research, development, and commercialization of synthetic human pheromones. The company's core business revolved around its proprietary 'vomeropherin' technology, which targeted the vomeronasal organ to elicit specific emotional and physiological responses. Its products were primarily licensed for use in the consumer fragrance and personal care markets, most notably through partnerships with major brands like Victoria's Secret and Avon. While the company initially explored therapeutic applications for mood and stress, it transitioned primarily into a licensing model for consumer goods before eventually ceasing active operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Human Pheromone Sciences.